HLNE Hamilton Lane INC Insider Trading

Executive Co-Chairman Hartley R. Rogers purchases 38,290 shares (38.3K) for $3,005,339.26 at HLNE via private placement, not discretionary open market.

Hartley R. Rogers, Executive Co-Chairman of Hamilton Lane INC, completed 2 separate purchases totaling 38,290 shares for $3,005,339.26 on 2026-06-11, increasing his holdings from 55,466 to 93,756 shares (+69.0% vs pre-transaction holdings). However, this transaction is flagged as a private placement, PIPE, registered direct, or IPO allocation — not a discretionary open-market purchase — and therefore should not be interpreted as a buying signal driven by insider conviction. The blended average purchase price of $78.49 compares to a current price of $81.99, but the stock is -49.1% from its 52-week high of $161.13 and down -18.5% over the past 90 days. The company reports quarterly revenue of $198,589,000.00 and net income of $58,372,000.00 with annual revenue growth of +6.5% and a P/E of 20.60. Because this is a scheduled allocation rather than discretionary market activity, the transaction's timing significance is materially different from open-market buys.

COO Andrea Anigati Kramer buys 1,283 HLNE shares at $77.46 via private placement—not discretionary open-market purchase.

This transaction is a private placement, not a discretionary open-market purchase driven by insider conviction, so it should not be interpreted as a buying signal. Kramer's prior buy at HLNE on 2026-02-20 has delivered a 90-day return of -17.6%, and her cross-ticker track record shows 0 of 1 buys well-timed at the 90-day mark with an average 90-day return of -17.6%. HLNE stock has declined -49.1% from its 52-week high of $161.13 and is currently trading at $81.99, down -3.7% over 30 days and -18.5% over 90 days. The company's fundamentals—revenue of $198,589,000.00, net income of $58,372,000.00, and 6.5% annual revenue growth—remain solid, but the allocation structure and poor timing history on prior HLNE activity suggest investors should focus on the company's operational and financial performance rather than reading conviction into this structured acquisition.

Director David J Berkman buys 15,000 HLNE shares at $76.27; holdings triple to 25,000 post-transaction as stock trades -49.1% from 52-week high.

David J Berkman, a director of Hamilton Lane INC, purchased 15,000 shares at $76.27 on 2026-06-11, increasing his holdings by 150.0% from 10,000 to 25,000 shares. The buy occurred as the stock has declined -49.1% from its 52-week high of $161.13 and -3.7% over the past 30 days. His timing on prior open-market transactions at this ticker shows a 90-day return of -10.6%, with 0 of 1 prior buys classified as well-timed at the 90-day mark. A cluster pattern exists with 2 other insiders also purchasing within the past 14 days. The company shows solid fundamentals with Revenue $198,589,000.00 and Net income $58,372,000.00, along with Annual revenue growth of +6.5%, though valuation pressures appear reflected in the stock's recent weakness.

Hamilton Lane exec Hartley Rogers acquires 110,932 shares for $9,992,337.70 via private placement at blended $90.08/share

Hartley R. Rogers, Executive Co-Chairman of Hamilton Lane INC, acquired 110,932 shares through 6 separate transactions on 2026-05-26 and 2026-05-27 for $9,992,337.70 at a blended average price of $90.08. The current stock price is $86.15, reflecting a -51.9% decline from the 52-week high of $179.19. However, this transaction is flagged as a private placement, PIPE, registered direct, or IPO allocation — not a discretionary open-market purchase, and therefore should not be interpreted as conviction-driven activity. Post-transaction, Rogers holds 55,466 shares. The company reported recent revenue of $198,589,000.00 and net income of $58,372,000.00, with annual revenue growth of +6.5% and a P/E of 21.65.

Director David Berkman buys 10,000 HLNE shares at $101.00; stock down 39.5% from 52-week high; 4 other insiders also bought in past 14 days

Director David Berkman initiated a position in Hamilton Lane with a 10,000-share purchase at $101.00, representing his first recorded holdings in the company. This transaction occurs within a broader cluster pattern: 4 other insiders have also purchased shares within the past 14 days. The stock's current price of $106.23 is down 39.5% from its 52-week high of $175.49 and down 28.3% over the past 30 days, suggesting the company is trading at a significant discount to recent levels. With annual revenue growth of 28.7% and a P/E of 26.69, the fundamental profile shows continuing growth momentum despite the recent sharp price decline. The concurrent buying by multiple insiders at depressed valuations warrants investor attention to understand whether the cluster reflects new information-driven conviction or routine portfolio actions.

Co-CEO Hirsch bought 9,225 shares of HLNE at $107.13; stock down 42.0% from 52-week high. Cluster: 4 other insiders also bought in past 14 days.

Hirsch Erik R., Co-Chief Executive Officer, purchased 9,225 shares at $107.13 on 2026-02-20, increasing his holdings by 15.1% to 70,494 shares total. The purchase occurs as HLNE trades at $101.75, down 42.0% from its 52-week high of $175.49 and down 31.9% over the past 30 days. The company posted strong recent fundamentals with Revenue $198,589,000.00 and Net income $58,372,000.00 in its latest quarter, alongside 28.7% annual revenue growth. This transaction is part of a cluster pattern: 4 other insiders also bought within the past 14 days, suggesting coordinated insider accumulation during a period of significant stock decline. The combination of management-level purchasing activity, sustained operational strength, and multi-insider concurrent buying merits investor attention as a potential signal of insider perspective on valuation during volatility.

HLNE COO Andrea Anigati buys 2,325 shares at $107.53 amid -42.0% drawdown; 4 other insiders bought within 14 days

Andrea Anigati, Chief Operating Officer of Hamilton Lane INC, purchased 2,325 shares at $107.53 on 2026-02-20, increasing her holdings to 65,761 shares. This transaction occurred as the stock trades -42.0% below its 52-week high of $175.49 and has declined -31.9% over the past 30 days. Notably, 4 other insiders also executed purchases within the past 14 days, forming a coordinated cluster buy pattern. The company's fundamentals remain solid with $198.6M in latest quarterly revenue, $58.4M net income, and 28.7% annual revenue growth, though the recent sharp price depreciation presents the timing context for this insider accumulation.

Co-CEO Delgado-Moreira buys 9,225 shares at $107.24 avg; stock down 42.0% from 52-week high; 4 other insiders buying within 14 days

Delgado-Moreira executed 2 separate purchases totaling 9,225 shares for $989,311.01 at a blended average price of $107.24 on 2026-02-20, increasing his holdings to 1,338,047 shares. The timing coincides with a significant valuation decline: the stock is trading at $101.75, down 42.0% from its 52-week high of $175.49 and down 31.9% over the past 30 days. His prior three trades at HLNE show mixed outcomes, with 2 of 3 achieving positive 90-day returns, though the most recent November purchases saw initial declines (−3.6% and −4.3% at 30 days). The filing also reflects a cluster pattern—4 other insiders purchased shares within the past 14 days—suggesting coordinated board-level or management recognition of valuation opportunity. Company fundamentals remain solid with $198.6M quarterly revenue, $58.4M net income, and 28.7% annual revenue growth, though the elevated P/E of 25.57 persists despite the price decline.

Executive Co-Chairman Giannini buys 9,225 shares of HLNE at $107.32; stock down 42.0% from 52-week high amid 4-insider buy cluster.

Mario L. Giannini, Executive Co-Chairman of Hamilton Lane Inc., purchased 9,225 shares at $107.32 on 2026-02-20, increasing his holdings by +9.6% to 105,723 shares total. The transaction occurs against a backdrop of significant price deterioration: the stock is currently $101.75, representing a -42.0% decline from its 52-week high of $175.49 and a -31.9% drop over the past 30 days. Notably, this purchase is part of a 4-insider cluster buy pattern within the past 14 days, suggesting coordinated accumulation at depressed levels. Despite the recent sharp price declines, the company's fundamentals remain solid with $198.6M in latest-quarter revenue, $58.4M in net income, and +28.7% annual revenue growth, creating a disconnect between operational performance and market valuation.

Co-CEO Delgado-Moreira buys 8,000 HLNE shares for $1.0M at blended avg $130.35

Co-Chief Executive Officer Juan Delgado-Moreira executed 2 purchases totaling 8,000 shares for $1,042,831.76 at a blended average price of $130.35, increasing his holdings from 1,306,447 to 1,314,447 shares. The stock is currently trading at $130.35, matching the transaction price, but sits -35.4% from its 52-week high of $201.62 and has declined -17.8% over the past 90 days despite a +10.2% gain in the last 30 days. Notably, his prior buy at HLNE on 2024-11-11 yielded -13.8% and -17.2% returns at 30 and 90 days respectively, and his cross-ticker track record shows 0 of 1 prior buys were well-timed at the 90-day mark. The company reports strong fundamentals (net income $70.9M, revenue growth +28.7% annually), but the confluence of a poorly-timed prior purchase at the same ticker and recent price weakness warrants attention to whether this purchase reflects conviction or follows a pattern of ill-timed entry points.